Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
A2 Biotherapeutics
company
About
A2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.
- Agoura Hills,California,United States
- 51 - 100
- https://www.a2bio.com
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $62M
- Industries
- Biotechnology,Health Care,Life Science
- Founded date
- Jan 1, 2018
- Number Of Employee
- 51 - 100
- Operating Status
- Active
- Legal Name
- A2 Biotherapeutics, Inc
A2 Biotherapeutics is an early-stage biotechnology company located in Southern California that develops novel medicines for serious illnesses. They utilize an advanced targeting technology platform to increase the effectiveness of the body’s natural immune defenses.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$190.50M
A2 Biotherapeutics has raised a total of
$190.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 19, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | Series B | $62M | — | — | — | Detail |
| Oct 6, 2020 | Series B | $71.50M | 8 | — | — | Detail |
| Nov 5, 2019 | Series A | $57M | 4 | — | — | Detail |
| Jan 1, 2019 | Seed | — | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
3
0
A2 Biotherapeutics has made 3 investments. Their most recent investment was on
Oct 19, 2020, when Genius Teacher raised $2M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 19, 2020
Genius Teacher
|
Angel | $2M | EdTech | — |
|
Sep 4, 2019
Atomberg Technology
|
Series A | $10M | Consumer Electronics | — |
|
Nov 9, 2015
Zilingo
|
Seed | $1.88M | E-Commerce | — |
Investors
Number of Lead Investors
Number of Investors
—
8
A2 Biotherapeutics is funded by 8 investors.
Casdin Capital
and Euclidean Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Casdin Capital
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
|
|
— | Series B |
Samsara BioCapital
|
— | Series B |
The Column Group
|
— | Series B |
|
|
— | Series B |
Vida Ventures
|
— | Series B |
Employee Profiles
Number of Employee Profiles
6
A2 Biotherapeutics has 6 current employee profiles, including
Executive Alexander Kamb
Executive
Executive
Executive
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
